...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Synthesis, Molecular Modeling, and Biological Evaluation of Novel Benzimidazole Derivatives as Inhibitors of Hepatitis C Virus RNA Replication
【24h】

Synthesis, Molecular Modeling, and Biological Evaluation of Novel Benzimidazole Derivatives as Inhibitors of Hepatitis C Virus RNA Replication

机译:新型苯并咪唑衍生物作为丙型肝炎病毒RNA复制抑制剂的合成,分子建模和生物学评估

获取原文
           

摘要

In this study, synthesis and docking studies of a series of new benzimidazole derivatives linked to substituted pyrimidines either through the methylenethio linkage or its bioisosteric methylene amino bridge were carried out. All the synthesized compounds were evaluated for their hepatitis C virus (HCV) RNA replication-inhibitory activity. Compounds 4d , 4f , and 4h were found to be more potent than VX-950 (IC50/90 of 4d =0.123/0.321, 4f =0.145/0.345, 4h =0.129/0.432, VX-950=0.20/0.45?μM, respectively) and 6d (IC50/90=0.116/0.452?μM) displayed activity very similar to that of the standard. Compounds 4d , 4f , 4h , and 6d were potent HCV RNA replication inhibitors and are good drug candidates for further investigations.
机译:在这项研究中,进行了一系列新的苯并咪唑衍生物的合成和对接研究,这些衍生物通过亚甲基硫键或其生物等位亚甲基氨基桥连接到取代的嘧啶上。评价所有合成的化合物的丙型肝炎病毒(HCV)RNA复制抑制活性。发现化合物4d,4f和4h比VX-950更有效(4d的IC 50/90 = 0.123 / 0.321、4f = 0.145 / 0.345、4h = 0.129 / 0.432,VX-分别为950 = 0.20 / 0.45?μM)和6d(IC 50/90 = 0.116 / 0.452?μM)表现出与标准品非常相似的活性。化合物4d,4f,4h和6d是有效的HCV RNA复制抑制剂,是进一步研究的良好候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号